Shanghai - Delayed Quote CNY
Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS)
13.52
+0.50
+(3.84%)
At close: June 6 at 3:00:04 PM GMT+8
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 2 |
| Avg. Estimate | -- | -- | 731.7M | 1.08B |
| Low Estimate | -- | -- | 731.7M | 1.02B |
| High Estimate | -- | -- | 731.7M | 1.14B |
| Year Ago Sales | -- | -- | 417.8M | 731.7M |
| Sales Growth (year/est) | -- | -- | 75.13% | 47.61% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 688488.SS | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Related Tickers
688222.SS HitGen Inc.
16.87
-0.82%
2162.HK Keymed Biosciences Inc.
47.800
+4.03%
196170.KQ ALTEOGEN Inc.
368,500.00
-3.28%
ATNF 180 Life Sciences Corp.
1.0400
-0.95%
BLTE Belite Bio, Inc
59.68
-7.07%
4724.TWO Meribank Biotech Co., Ltd
17.75
+2.90%
SPRC SciSparc Ltd.
0.3120
-1.89%
6696.TWO Lin BioScience, Inc.
140.00
+1.08%
22UA.DE BioNTech SE
96.50
-0.82%
URGN UroGen Pharma Ltd.
7.37
+43.39%